T7 Pep-LNP is a state-of-the-art peptide-functionalized lipid nanoparticle (LNP), designed for efficient targeted delivery of therapeutic cargoes such as siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems. Engineered with the T7 peptide, this LNP system demonstrates enhanced specificity and binding affinity towards cells expressing the transferrin receptor (TfR). This peptide can selectively recognize and bind to TfR, which is highly expressed on various cell types, thereby conferring the LNP active targeting capabilities. Our LNP is prepared using Targeting Module and a variety of optional lipid formulations including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and others. These formulations are carefully selected to ensure the LNP has uniform particle size, high encapsulation efficiency, stability, and targeted delivery. Applications of T7 Pep-LNP span a wide range of therapeutic areas, including potential treatments for neurodegenerative diseases like Alzheimer's and Parkinson's, targeted cancer therapy, gene therapy for genetic disorders, and advanced vaccine development. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.